CLINICAL TRIALS DIVERSITY
Apr 7, 2022 | Boston Business Journal
5% 20/367
New approaches to drug studies could pave the way for more diversity
The push to make it easier for patients to participate in clinical trials has been in the works for years. Covid-19 forced companies’ hands, now decentralized and hybrid trials are here.
Rowan Walrath
Share your vote
